About the Neurology ® journals
About NeurologyAbout Neurology 
Neurology is the official journal of the American Academy of Neurology.
Vision: Neurology will be the premier peer-reviewed journal for clinical neurology research.
Mission: Neurology will publish outstanding peer-reviewed original research articles, editorials, and reviews to enhance patient care, education, clinical research, and professionalism.
As the leading clinical neurology journal worldwide, Neurology is directed to physicians concerned with diseases and conditions of the nervous system. The journal's purpose is to advance the field by presenting new basic and clinical research with emphasis on knowledge that will influence the way neurology is practiced. The journal is at the forefront in disseminating cutting-edge, peer-reviewed information to the neurology community worldwide. Editorial content includes Research, Clinical/Scientific Notes, Views & Reviews (including Medical Hypothesis papers), Issues of Neurological Practice, Historical Neurology, NeuroImages, Humanities, Disputes & Debates: Editors’ Choice, and position papers from the American Academy of Neurology. Contents appearing solely online include the Patient Page, CME Quizzes, Podcasts, and play-in-place video. The online version is considered the canonical version of the journal because it includes all content available to the reader.
The 2022 Journal Impact Factors for our Neurology® journals were recently released. Impact Factors indicate the number of citations to articles published in the last two full calendar years and help authors decide where to publish papers. The 2022 Impact Factors received were:
- Neurology®: 10.1
- Neurology® Clinical Practice: 2.2
- Neurology® Genetics: 4.1
- Neurology® Neuroimmunology & Neuroinflammation: 8.8
Neurology is indexed in MEDLINE/PubMed, Embase, Scopus, Biological Abstracts®, PsycINFO®, Current Contents®, Web of Science®, CrossRef, and Google Scholar. Funded articles are indexed in PMC.
About Neurology: Clinical Practice
Neurology: Clinical Practice is an official journal of the American Academy of Neurology.
Vision: Neurology: Clinical Practice will be the premier peer-reviewed journal to improve patient outcomes in clinical neurology.
Mission: Neurology: Clinical Practice aims to help clinicians provide unbiased, high-quality care for all neurologic patients. We prioritize papers that address quality, patient outcomes, and practice-related topics.
Neurology: Clinical Practice (NCP) focuses mainly on two aspects of neurologic care: 1) Clinical research on patient-reported outcomes and quality, including original research articles and meta-analyses/systematic reviews; and 2) Commentaries, reviews, and research articles on general practice, billing and coding, wellness and burnout, diversity and inclusion in the workplace, telehealth, health care policy, and financial management. NCP publishes content online continuously and produces 6 issues per year that are also available to subscribers and US members in print. The Editors reserve the right to decide which content will be published online-only. Priority for online-only publication is given to original research articles and systematic reviews/meta-analyses. Innovations in Neurologic Practice, Case Reports, and Practice Current articles are published online only.
We will continue to consider a small number of selected case reports, prioritizing those that aim to help neurologists in all career stages and practice settings to diagnose and treat patients who present with challenging symptoms and conditions. This includes case series and other content that especially lends itself to presentation in a digital format, such as videos and interactive figures. NCP will not consider NeuroImage or Video NeuroImage submissions. We will consider submissions to a new special category titled “Innovations in Neurologic Practice,” presenting short, focused pieces on the most impactful aspects of care in neurology. These pieces will highlight up-to-date diagnostic tools and treatment strategies for the benefit of community and hospital-based practitioners.
The 2022 Impact Factor for Neurology: Clinical Practice is 2.2.
Note: NCP papers may be published online only or in print and online at the discretion of the editor. Abstracts of NCP articles are delivered to PubMed Central (PMC) after they publish online and are searchable shortly thereafter. Abstracts listed in PMC will include the DOI linking to the full article on the NCP website. Complete NCP articles will be available in PMC one year after publication. NCP is currently indexed in Embase, Scopus, CrossRef, Google Scholar, and Emerging Sources Citation Index.
About Neurology: Genetics
Neurology: Genetics is an official journal of the American Academy of Neurology.
Vision: Neurology: Genetics will be a premier peer-reviewed journal in the field of human neurogenetics.
Mission: Neurology: Genetics will provide neurologists, geneticists, and neuroscientists with outstanding original contributions that elucidate the role of genetic and epigenetic variations in disease and biological traits of the central and peripheral nervous systems as well as investigations of therapeutic approaches for these disorders.
Neurology: Genetics is an online open access journal publishing peer-reviewed reports in the field of neurogenetics. The journal publishes original articles in all areas of neurogenetics including rare and common genetic variations, genomics, genotype-phenotype correlations, outlier phenotypes as a result of mutations in known disease genes, genetic variations with a putative link to diseases, and translational research in these disorders.
Our interests include studies on genetic disease risk, pharmacogenomics, polygenic risk scores, transcriptomics and translatomics, mendelian randomization as well as studies on natural history, clinical outcome measures, biomarkers and clinical trials.
Genetically engineered model systems are not a primary focus of Neurology: Genetics, but studies using model systems to understand human diseases with a focus on biomarker development, transcriptomics and preclinical treatment trials are welcome. This includes well-powered studies reporting negative results.
The 2022 Impact Factor for Neurology: Genetics is 4.1.
Neurology: Genetics is indexed in PMC, Google Scholar, DOAJ, and CrossRef.
About Neurology: Neuroimmunology & Neuroinflammation
Neurology: Neuroimmunology & NeuroInflammation is an official journal of the American Academy of Neurology.
Vision: Neurology: Neuroimmunology & Neuroinflammation will be the premier peer-reviewed journal in the fields of neuroimmunology and neuroinflammation.
Mission: Neurology: Neuroimmunology & Neuroinflammation will provide neurologists and clinical research scientists with outstanding peer-reviewed articles, editorials, and reviews to enhance patient care and facilitate basic and translational research..
We publish rigorously peer-reviewed open access reports of original research and in-depth reviews of topics in neuroimmunology & neuroinflammation, affecting the full range of neurologic diseases including (but not limited to): Alzheimer disease, Parkinson disease, ALS, tauopathy, and stroke; multiple sclerosis and NMO; inflammatory peripheral nerve and muscle disease, Guillain-Barré and myasthenia gravis; nervous system infection; paraneoplastic syndromes, noninfectious encephalitides and other antibody-mediated disorders; and psychiatric and neurodevelopmental disorders. Clinical trials, instructive case reports, and small case series will also be featured.
The 2022 Impact Factor for Neurology: Neuroimmunology & Neuroinflammation is 8.8.
Neurology: Neuroimmunology & Neuroinflammation is indexed in MEDLINE/PubMed, PMC, Scopus, EMBASE, Google Scholar, DOAJ, CrossRef, Science Citation Index Expanded (SCIE), and Current Contents®/Clinical Medicine.
About Neurology: Education
Neurology: Education is an official journal of the American Academy of Neurology.
Vision: Neurology: Education is a premier peer-reviewed journal in the field of neurologic and neuroscience education research.
Mission: Neurology: Education publishes original research articles, reviews, and editorials on evidence-based teaching methods and curriculum innovations, and provides the academic community with a forum to exchange ideas that enhance teaching and training in neurology and neuroscience.
Neurology: Education is a peer-reviewed journal to inform the science of teaching, learning, and training. Neurology: Education provides educators, clinicians, and trainees with outstanding peer-reviewed research articles, reviews, and editorials that address medical and neurologic education, including evidence-based teaching methods and curriculum innovations. The journal is a forum for the academic community to enhance teaching and learning in neurology and related fields. Neurology: Education publishes articles on all stages of neurologic and neuroscience education including premedical, postgraduate, and continuing medical education in neurology and related professions. The journal is online-only with continuous publication.
About the AAN
- Supporting members across their professional lifetime
- Educating members to foster high-quality clinical care and science
- Advocating for members and their patients
- Supporting and promoting member involvement in neurologic research
- Maximizing organizational effectiveness to meet member needs
A neurologist is a doctor with specialized training in diagnosing, treating, and managing disorders of the brain and nervous system such as Alzheimer disease, stroke, migraine, multiple sclerosis, brain injury, Parkinson disease, and epilepsy.
For more information about the American Academy of Neurology, visit AAN.com or find us on Facebook, Twitter and YouTube.
About the Publisher
Copyright and Permissions
Opinions expressed by the authors are not necessarily those of the American Academy of Neurology, its affiliates, or of the Publisher. The American Academy of Neurology, its affiliates, and the Publisher disclaim any liability to any party for the accuracy, completeness, efficacy, or availability of the material contained in this publication (including drug dosages) or for any damages arising out of the use or non-use of any of the material contained in this publication.
Neurology: Neuroimmunology & Neuroinflammation and Neurology: Genetics use the Creative Commons License Attribution-NonCommercial No Derivative License (CCBY-NC-ND) and Creative Commons Attribution License (CC-BY) for articles and content published.
Use of the CCBY-NC-ND enables authors/creators of content to retain ownership of the copyright for their article/content and gives the American Academy of Neurology a license to publish the content. The CCBY-NC-ND agreement allows anyone to disseminate and reuse the article, as well as share and reuse of the scientific material, provided the original authors and original source (Neurology: Neuroimmunology & Neuroinflammation and Neurology: Genetics reference) is given. Such downloading, use, reuse, etc. does not require permission from either the authors or the publisher. It does not allow commercial exploitation or the creation of derivative works without specific permission. To view a copy of this license, visit: http://creativecommons.org/licenses/by-nc-nd/4.0.
Authors funded by Austrian Science Fund, Bill & Melinda Gates Foundation, Research Councils of United Kingdom, Swedish Research Council, Telethon Italy, Wellcome Trust/COAF Partners, National Institutes of Health Research [UK] (NIHR), or World Bank, may publish open access using the Creative Commons Attribution License (CC-BY). Use of the CC-BY license enables authors/creators of content to retain ownership of the copyright for their article/content and gives the American Academy of Neurology a license to publish the content. The CC-BY agreement allows anyone to reuse the article and create derivatives, even for commercial purposes, provided the original authors and original source (Neurology: Neuroimmunology & Neuroinflammation and Neurology: Genetics reference) is given. Such downloading, use, reuse, and derivative creation does not require permission from either the authors or the publisher. To view a copy of this license, visit: http://creativecommons.org/licenses/by/4.0.
Licensing, Translation Rights & Licensing queries: Please contact Andrew Wible, Senior Manager, Rights, Licensing, and Partnerships, Wolters Kluwer; [email protected].For the Press
Articles appearing in the print journals, Neurology and Neurology: Clinical Practice, are embargoed for release to the public until 4:00 PM, ET, the day before the Tuesday print publication date. If the full article is chosen to be published online ahead of print publication, the paper and its findings would be embargoed until 4:00 PM, ET, the day of online publication to Neurology.org or Neurology.org/cp.
Neurology: Neuroimmunology & Neuroinflammation (Neurology.org/nn) and Neurology: Genetics (Neurology.org/ng) are online-only and articles are published on a continuous basis; findings are embargoed until 4:00 PM, ET, the day of online publication.
Credentialed representatives of the press may request further information about embargoed Neurology, Neurology: Clinical Practice, Neurology: Neuroimmunology & Neuroinflammation, and Neurology: Genetics articles, including advance copies of articles and help coordinating interviews with researchers, by contacting the American Academy of Neurology Media and Public Relations Department: Renee Tessman at [email protected].
View Post-embargo Press Releases at https://www.aan.com/pressroom/.
Hastening the Diagnosis of Amyotrophic Lateral Sclerosis
Dr. Brian Callaghan and Dr. Kellen Quigg